Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

被引:62
|
作者
Overbeek, Maria J. [1 ]
Mouchaers, Koen T. B. [1 ]
Niessen, Hans M. [2 ,3 ]
Hadi, Awal M. [1 ]
Kupreishvili, Koba [2 ]
Boonstra, Anco [1 ]
Voskuyl, Alexandre E. [4 ]
Belien, Jeroen A. M. [2 ]
Smit, Egbert F. [1 ]
Dijkmans, Ben C. [4 ]
Vonk-Noordegraaf, Anton [1 ]
Grunberg, Katrien [2 ]
机构
[1] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pulm Dis, Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Cardiac Surg, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1155/2010/604615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a disturbed function of the right ventricle (RV) when compared to idiopathic PAH (IPAH). Systemic sclerosis may also affect the heart. We hypothesize that RV differences may occur at the level of interstitial inflammation and-fibrosis and compared inflammatory cell infiltrate and fibrosis between the RV of SScPAH, IPAH, and healthy controls. Methods. Paraffin-embedded tissue samples of RV and left ventricle (LV) from SScPAH (n = 5) and IPAH (n = 9) patients and controls (n = 4) were picrosirius red stained for detection of interstitial fibrosis, which was quantified semiautomatically. Neutrophilic granulocytes (MPO), macrophages (CD68), and lymphocytes (CD45) were immunohistochemically stained and only interstitial leukocytes were counted. Presence of epi-or endocardial inflammation, and of perivascular or intimal fibrosis of coronary arteries was assessed semiquantitatively (0-3: absent to extensive). Results. RV's of SScPAH showed significantly more inflammatory cells than of IPAH (cells/mm(2), mean +/- sd MPO 11 +/- 3 versus 6 +/- 1; CD68 11 +/- 3 versus 6 +/- 1; CD45 11 +/- 1 versus 5 +/- 1, P < .05) and than of controls. RV interstitial fibrosis was similar in SScPAH and IPAH (4 +/- 1 versus 5 +/- 1%, P = .9), and did not differ from controls (5 +/- 1%, P = .8). In 4 SScPAH and 5 IPAH RV's foci of replacement fibrosis were found. No differences were found on epi-or endocardial inflammation or on perivascular or intimal fibrosis of coronary arteries. Conclusion. SScPAH RVs display denser inflammatory infiltrates than IPAH, while they do not differ with respect to interstitial fibrosis. Whether increased inflammatory status is a contributor to altered RV function in SScPAH warrants further research.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Clinical Characteristics And Survival Of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Diagnosed By A Systematic Detection Program
    Humbert, M. J. C.
    Yaici, A.
    De Groote, P.
    Montani, D.
    Sitbon, O.
    Launay, D.
    Gressin, V.
    Guillevin, L.
    Clerson, P.
    Simonneau, G.
    Hachulla, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [42] Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension A Comparison of Demographic, Hemodynamic, and SRI Characteristics and Outcomes
    Ramjug, Sheila
    Hussain, Nehal
    Hurdman, Judith
    Billings, Catherine
    Charalampopoulos, Athanasios
    Elliot, Charlie A.
    Kiely, David G.
    Sabroe, Ian
    Rajaram, Smitha
    Swift, Andrew J.
    Condliffe, Robin
    CHEST, 2017, 152 (01) : 92 - 102
  • [43] Clinical Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-associated Interstitial Lung Disease
    Han, Kyung-Il
    Hwang, Jung Hwa
    Nam, Bo Da
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [44] Progress in progressive pulmonary fibrosis: biomarkers of systemic sclerosis-associated interstitial lung disease
    Takada, Toshinori
    RHEUMATOLOGY, 2024, 63 (11) : 2907 - 2908
  • [45] A Systemic Review of Factors Associated with Systemic Sclerosis-associated Pulmonary Arterial Hypertension (SSc-PAH)
    Jiang, Yuxuan
    Turk, Matthew
    Pope, Janet
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] Impact Of Initial Combination Therapy On Hemodynamics And Right Ventricular Mass In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Gashouta, M. A.
    Corona-Villalobos, C. P.
    Mathai, S. C.
    Damico, R. L.
    Kolb, T. M.
    Zimmerman, S.
    Girgis, R. E.
    Minai, O. A.
    Zamanian, R. T.
    Torres, F.
    Hassoun, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [47] Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension
    Hsu, Steven
    Kokkonen-Simon, Kristen M.
    Kirk, Jonathan A.
    Kolb, Todd M.
    Damico, Rachel L.
    Mathai, Stephen C.
    Mukherjee, Monica
    Shah, Ami A.
    Wigley, Fredrick M.
    Margulies, Kenneth B.
    Hassoun, Paul M.
    Halushka, Marc K.
    Tedford, Ryan J.
    Kass, David A.
    CIRCULATION, 2018, 137 (22) : 2360 - 2370
  • [48] Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile
    Papadimitriou, Theodoros Ioannis
    Lemmers, Jacqueline M. J.
    van Caam, Arjan P. M.
    Vos, Jacqueline L.
    Vitters, Elly L.
    Stinissen, Lizan
    van Leuven, Sander, I
    Koenders, Marije, I
    van der Kraan, P. M.
    Koenen, Hans J. P. M.
    Smeets, Ruben L.
    Nijveldt, Robin
    Vonk, Madelon C.
    Thurlings, Rogier M.
    RHEUMATOLOGY, 2024, 63 (09) : 2525 - 2534
  • [49] Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez, Sergio A.
    Piera-Velazquez, Sonsoles
    MATRIX BIOLOGY, 2016, 51 : 26 - 36
  • [50] Changing Characteristics of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
    Lapatra, T.
    Al-Naamani, N.
    Song, N.
    Pinder, D.
    Patel, M.
    Goodman, R.
    Narasimmal, S.
    McCormick, A.
    Lucki, J.
    Burwell, C.
    Smith, A.
    Mazurek, J. A.
    Archer-Chicko, C. L.
    Palevsky, H. I.
    Fritz, J. S.
    Pugliese, S.
    Kawut, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)